Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Welireg (generic name: Vorolanib, brand name: Welireg) is a drug developed by Sanofi, primarily used for the treatment of certain types of cancer. It is a targeted therapy, specifically used for the treatment of certain advanced or metastatic renal cell carcinoma (RCC).